Skip to content

Clinical trials

Phase 2/3 Obesity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 2/3 Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20034
20043
20057
20063
20072
20085
20099
20108
20112
20121
20133
20149
20167
20174
20182
20195
20202
20214
20228
20234
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Unknown status12
Recruiting5
Withdrawn5
Active, not recruiting4
Terminated3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University10
Xiaojun Chen5
Mayo Clinic3
Catalysis SL2
Hanyang University2
Joslin Diabetes Center2
Kaiser Permanente2
National Nutrition and Food Technology Institute2
The Miriam Hospital2
University of Campinas, Brazil2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity101
Overweight19
Diabetes Mellitus, Type 212
Weight Loss9
Binge-Eating Disorder7
Insulin Resistance7
Diabetes Mellitus6
Endometrial Hyperplasia5
Hypertension4
Infertility4

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.